Hersant Barbara, SidAhmed-Mezi Mounia, Bosc Romain, Meningaud Jean-Paul
Barbara Hersant, MD, is a Plastic Surgeon; Mounia SidAhmed-Mezi, PhD, is a Researcher; Romain Bosc, MD, is a Plastic Surgeon; and Jean-Paul Meningaud, MD, PhD, is Chief, Department of Plastic Cosmetic and Reconstructive Surgery, and is a Plastic and Maxillo-facial Surgeon, Henri Mondor Hospital, Paris, France.
Adv Skin Wound Care. 2017 Nov;30(11):502-508. doi: 10.1097/01.ASW.0000524399.74460.87.
Managing cutaneous substance loss after debridement is challenging, especially if it is secondary to necrotizing soft tissue infection, such as necrotizing fasciitis and Fournier gangrene. After skin graft reconstruction, the healing process is longer and may be difficult, depending on the wound site, skin defect size, and patient comorbidities.
The aim of this study was to investigate whether autologous platelet-rich plasma (A-PRP) could accelerate and improve wound healing after cutaneous reconstruction for tissue loss secondary to soft tissue infection.
A prospective, controlled, randomized, open-label study was conducted. Patients (N = 27) were randomized into 2 groups by drawing lots using sealed envelopes: an experimental (n = 14) and a control group (n = 13). Initially, all the necrotic tissue was extensively debrided and excised. In the experimental group, patients underwent a split-thickness skin graft (STSG) combined with A-PRP/thrombin gel sprayed on the wound bed and on the STSG after staple fixation. In the control group, patients underwent an STSG alone.
Results showed that the mean complete healing time was significantly reduced (by almost 50%) when A-PRP/thrombin gel was combined with an STSG compared with STSG alone (37.9 [SD, 14.3] days in the experimental group vs 73.7 [SD, 50.84] days in the control group, P = .01). No patient experienced complications during the follow-up period.
The combination of A-PRP/thrombin gel and an STSG significantly improved clinical outcomes and shortened the wound healing time. Therefore, this treatment combination could provide a way to heal skin after a necrotizing soft tissue infection with minimal recovery time.
清创术后处理皮肤组织缺损具有挑战性,尤其是继发于坏死性软组织感染,如坏死性筋膜炎和福尼尔坏疽时。皮肤移植重建后,愈合过程较长且可能困难,这取决于伤口部位、皮肤缺损大小和患者的合并症。
本研究旨在调查自体富血小板血浆(A-PRP)是否能加速并改善软组织感染继发组织缺损的皮肤重建术后伤口愈合。
进行了一项前瞻性、对照、随机、开放标签研究。通过使用密封信封抽签将患者(N = 27)随机分为2组:实验组(n = 14)和对照组(n = 13)。最初,所有坏死组织均被广泛清创和切除。在实验组中,患者接受了断层皮片移植(STSG),并在钉合固定后将A-PRP/凝血酶凝胶喷洒在伤口床和STSG上。在对照组中,患者仅接受了STSG。
结果显示,与单独使用STSG相比,A-PRP/凝血酶凝胶与STSG联合使用时,平均完全愈合时间显著缩短(近50%)(实验组为37.9 [标准差,14.3]天,对照组为73.7 [标准差,50.84]天,P = 0.01)。在随访期间,没有患者出现并发症。
A-PRP/凝血酶凝胶与STSG联合使用显著改善了临床结果并缩短了伤口愈合时间。因此,这种治疗组合可为坏死性软组织感染后的皮肤愈合提供一种恢复时间最短的方法。